摘要
目的:观察鞘内注射地塞米松(DXM)联合甲基强的松龙(MP)冲击治疗急性格林-巴利综合征的临床疗效。方法:选择确诊为急性格林-巴利综合征的患者56例,随机分为治疗组和对照组,治疗组患者在鞘内注射地塞米松基础上联合MP冲击治疗,2次/周,每次鞘内注射地塞米松10mg,10次为1个疗程。治疗过程中动态观察脑脊液(CSF)中蛋白含量及细胞学动态变化,比较治疗前、后临床神经功能缺损程度评分(SSS)变化。结果:治疗组患者CSF蛋白含量恢复至正常,CSF细胞学检查,免疫活性细胞减少至恢复正常的时间较对照组提前1~2周;治疗组治疗后SSS评分与对照组比较差异有统计学意义(P<0.01);两组临床疗效比较,治疗组显效率明显高于对照组(P<0.05)。结论:鞘内注射地塞米松联合甲基强的松龙冲击治疗急性格林-巴利综合征是安全有效的方法,可以减轻病情,缩短病程。
Objective:Observation of intrathecal injection of dexamethasone(DXM)combined with methylprednisolone pulse therapy on acute(MP)Green-Barre syndrome.Methods:Diagnosed with acute Green-Barre syndrome in 56 cases,were randomly divided into treatment group and control group,patients in the treatment group intrathecal injection of dexamethasone pulse therapy joint based on MP,2 times a week,each time the intrathecal injection of dexamethasone 10mg,10 to 1 courses.During the treatment of dynamic observation of cerebrospinal fluid(CSF)in protein content and cytological changes,compare the changes of the clinical neurologic impairment score(SSS)in before and after treatment.Results:Patients in the treatment group CSF protein levels returned to normal,CSF cytology,immune active cells decreased to the normal time than the control group in 1 to 2 weeks;The treatment group after treatment with SSS score compared with the control group the differences were statistically significant(P0.01);Comparison of the clinical efficacy of the two groups,the treatment group showed the efficiency is obviously higher than the control group(P0.05).Conclusion:Intrathecal injection of dexamethasone combined with methylprednisolone pulse therapy in the treatment of acute Green-Barre syndrome is a safe and effective method,can alleviate the condition,shorten the course of disease.
出处
《医学理论与实践》
2012年第5期503-504,506,共3页
The Journal of Medical Theory and Practice